Two Single-nucleotide Polymorphisms in the 5' and 3' Ends of the Osteopontin Gene Contribute to Susceptibility to Systemic Lupus Erythematosus
Overview
Authors
Affiliations
Objective: To test the association of osteopontin (OPN) polymorphisms with systemic lupus erythematosus (SLE).
Methods: The coding 5' and 3' flanking regions of the OPN gene were scanned for polymorphisms by denaturing high-performance liquid chromatography. A case-control association study was performed in 394 Italian SLE patients and 479 matched controls. OPN serum levels were determined by enzyme-linked immunosorbent assay in 40 patients and 124 controls, and the mean levels were compared between the different OPN genotypes.
Results: Among the 13 detected single-nucleotide polymorphisms (SNPs), alleles -156G (frequency 0.714 versus 0.651; P = 0.006, corrected P [P(corr)] = 0.036) and +1239C (0.377 versus 0.297; P = 0.00094, P(corr) = 0.0056) were significantly increased in the SLE patients compared with the controls. The presence of the associated allele in single or double dose conferred an odds ratio (OR) of 2.35 (95% confidence interval [95% CI] 1.38-4.02) for SNP -156 and an OR of 1.57 (95% CI 1.16-2.13) for SNP +1239. These effects were independent of each other, i.e., not a consequence of linkage disequilibrium between the 2 alleles. The risk associated with a double dose of susceptibility alleles at both SNPs was 3.8-fold higher (95% CI 2.0-7.4) relative to the complete absence of susceptibility alleles. With regard to individual clinical and immunologic features, a significant association was seen between lymphadenopathy and -156 genotypes (overall P = 0.0011, P(corr) = 0.046). A significantly increased OPN serum level was detected in healthy individuals carrying +1239C (P = 0.002), which is indicative of an association between the SLE susceptibility allele and OPN levels.
Conclusion: These data suggest the independent effect of a promoter (-156) and a 3'-untranslated region (+1239) SNP in SLE susceptibility. We can speculate that these sequence variants (or others in perfect linkage disequilibrium) create a predisposition to high production of OPN, and that this in turn may confer susceptibility to SLE.
Rivera-Cameras A, Gallegos-Arreola M, Moran-Moguel M, Salazar-Paramo M, Alcaraz-Lopez M, Echeverria-Gonzalez G Int J Mol Sci. 2024; 25(2).
PMID: 38256074 PMC: 10816335. DOI: 10.3390/ijms25021000.
Elhossini R, Elbendary H, Rafat K, Ghorab R, Abdel-Hamid M Mol Genet Genomics. 2023; 298(3):709-720.
PMID: 37010587 PMC: 10133048. DOI: 10.1007/s00438-023-02009-1.
Kara B, Ekinci Z, Sahin S, Gungor M, Gunes A, Ozturk K Rheumatol Int. 2020; 40(11):1903-1910.
PMID: 32691099 PMC: 7369505. DOI: 10.1007/s00296-020-04653-x.
Kaleta B, Mroz P, Gorski A, Lukaszkiewicz J, Wozniacka A, Bogaczewicz J Postepy Dermatol Alergol. 2020; 37(2):190-194.
PMID: 32489353 PMC: 7262818. DOI: 10.5114/ada.2019.83499.
Kaleta B, Krata N, Zagozdzon R, Mucha K Cells. 2019; 8(6).
PMID: 31159229 PMC: 6628186. DOI: 10.3390/cells8060524.